James E Leone1, Kimberly A Wise1, Elizabeth M Mullin2, Kimberly A Gray3, Philip A Szlosek1, Matthew F Griffin1, Cara A Jordan4. 1. Department of Movement Arts, Health Promotion, and Leisure Studies, Bridgewater State University, Bridgewater, Massachusetts. 2. Exercise Science and Athletic Training Department, Springfield College, Springfield, Massachusetts. 3. Department of Kinesiology, Southern Illinois University, Carbondale, Illinois. 4. Department of Psychology, Bridgewater State University, Bridgewater, Massachusetts.
Abstract
BACKGROUND: Celiac disease (CD) is a common gastrointestinal pathology; however, prevalence and comorbidities are unknown in collegiate athletics. HYPOTHESES: (1) Athletes will have similar odds of CD as general population estimates (approximately 1 in 141) based on self-report and signs and symptoms, (2) athletes scoring higher on the Celiac Symptom Index (CSI) will have lower self-reported quality of life (QoL), (3) athletes scoring higher on the CSI will have higher depression scores, and (4) athletes scoring higher on the CSI will have higher perceived stress scores. STUDY DESIGN: Epidemiological cross-sectional study. LEVEL OF EVIDENCE: Level 4. METHODS: The CSI, WHO Quality of Life-BREF, Beck Depression Inventory, and Perceived Stress Scale were used to assess patients' signs and symptoms of CD and psychosocial measures/QoL in male and female National Collegiate Athletic Association (all divisions) athletes (N = 141). Participants also self-reported a formal diagnosis of CD. Chi-square analyses determined CD prevalence. Odds ratios determined risk for either being diagnosed with CD or reporting more symptoms than the general population. Correlational analyses determined whether symptoms correlated with QoL and psychosocial measures. RESULTS: Athletes were 3.85 times (95% CI, 0.42-34.89) more likely to report a CD diagnosis and were 18.36 times (95% CI, 2.40-140.48) more likely to report a high degree of CD symptoms than the general population. Athletes with more symptoms had worse physical, psychological, social, and environmental QoL indicators and higher depression and perceived stress scores. CONCLUSION: Athletes may be a higher risk population for experiencing CD and report greater signs/symptoms compared with general population estimates. Additionally, athletes with higher CD symptom scores also reported poorer QoL. CLINICAL RELEVANCE: Allied health care professionals should be aware of the diversity of CD symptoms and be prepared to refer athletes when gastrointestinal symptoms persist to ensure proper care and unhampered performance.
BACKGROUND: Celiac disease (CD) is a common gastrointestinal pathology; however, prevalence and comorbidities are unknown in collegiate athletics. HYPOTHESES: (1) Athletes will have similar odds of CD as general population estimates (approximately 1 in 141) based on self-report and signs and symptoms, (2) athletes scoring higher on the Celiac Symptom Index (CSI) will have lower self-reported quality of life (QoL), (3) athletes scoring higher on the CSI will have higher depression scores, and (4) athletes scoring higher on the CSI will have higher perceived stress scores. STUDY DESIGN: Epidemiological cross-sectional study. LEVEL OF EVIDENCE: Level 4. METHODS: The CSI, WHO Quality of Life-BREF, Beck Depression Inventory, and Perceived Stress Scale were used to assess patients' signs and symptoms of CD and psychosocial measures/QoL in male and female National Collegiate Athletic Association (all divisions) athletes (N = 141). Participants also self-reported a formal diagnosis of CD. Chi-square analyses determined CD prevalence. Odds ratios determined risk for either being diagnosed with CD or reporting more symptoms than the general population. Correlational analyses determined whether symptoms correlated with QoL and psychosocial measures. RESULTS: Athletes were 3.85 times (95% CI, 0.42-34.89) more likely to report a CD diagnosis and were 18.36 times (95% CI, 2.40-140.48) more likely to report a high degree of CD symptoms than the general population. Athletes with more symptoms had worse physical, psychological, social, and environmental QoL indicators and higher depression and perceived stress scores. CONCLUSION: Athletes may be a higher risk population for experiencing CD and report greater signs/symptoms compared with general population estimates. Additionally, athletes with higher CD symptom scores also reported poorer QoL. CLINICAL RELEVANCE: Allied health care professionals should be aware of the diversity of CD symptoms and be prepared to refer athletes when gastrointestinal symptoms persist to ensure proper care and unhampered performance.
Authors: Toni M Torres-McGehee; Kelly L Pritchett; Deborah Zippel; Dawn M Minton; Adam Cellamare; Mike Sibilia Journal: J Athl Train Date: 2012 Mar-Apr Impact factor: 2.860
Authors: Stuart Currie; Marios Hadjivassiliou; Matthew J R Clark; David S Sanders; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard Journal: J Neurol Neurosurg Psychiatry Date: 2012-08-20 Impact factor: 10.154
Authors: Anneli Ivarsson; Anna Myléus; Fredrik Norström; Maria van der Pals; Anna Rosén; Lotta Högberg; Lars Danielsson; Britta Halvarsson; Solveig Hammarroth; Olle Hernell; Eva Karlsson; Lars Stenhammar; Charlotta Webb; Olof Sandström; Annelie Carlsson Journal: Pediatrics Date: 2013-02-18 Impact factor: 7.124
Authors: Alberto Rubio-Tapia; Robert A Kyle; Edward L Kaplan; Dwight R Johnson; William Page; Frederick Erdtmann; Tricia L Brantner; W Ray Kim; Tara K Phelps; Brian D Lahr; Alan R Zinsmeister; L Joseph Melton; Joseph A Murray Journal: Gastroenterology Date: 2009-04-10 Impact factor: 22.682